Your browser is no longer supported. Please, upgrade your browser.
Settings
HELX Franklin Genomic Advancements ETF daily Stock Chart
HELX [AMEX]
Franklin Genomic Advancements ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-2.89%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month10.50%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter9.27%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y43.93%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range18.41 - 39.93 Perf YTD56.40%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-6.84% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low102.06% ATR0.79
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)56.79 Volatility1.88% 1.58%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.48 Prev Close37.48
ShortableNo LT Debt/Eq- Earnings- Payout- Avg Volume3.35K Price37.20
Recom- SMA202.38% SMA505.80% SMA20022.29% Volume480 Change-0.73%
Oct-05-20 08:00AM  
The investment seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.